.png)
Veterinary Oncology Market By Therapy, Animal and Cancer - Global Industry Analysis & Forecast to 2027
Published On : March 2022 Pages : 130 Category: Pharma & Healthcare Report Code : HC0317328
SEGMENTS & REGIONS:
- Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa
The global Veterinary Oncology Market is valued at USD 186.59 million in 2021 and is projected to reach USD XX million by the end of 2027, growing at a CAGR of XX% during the period 2022 to 2027.
Veterinary oncology is a subspecialty of veterinary medicine that deals with cancer diagnosis and treatment in animals. Cancer is a major cause of death in pet animals. Companion animals such as dogs and cats suffer from many of the same types of cancer as humans.
The report exhibit detail coverage of Veterinary Oncology industry and market trends. The report also analyses present and past market values to forecast potential market through the forecast period between 2027-2027.This research study of Veterinary Oncology Market involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
In addition, the report provides insight into main drivers, challenges, opportunities and risk of the market and strategies of suppliers. Key players are profiled as well. Overall, this report covers the historical situation, present status and the future prospects of the global Veterinary Oncology Market for 2022-2027.
Crystal Market Research envisions that the span of the Veterinary Oncology Market will develop amid the estimated time frame as the Compound Annual Growth Rate boosts significantly. The objective of the market research report is the current status of the market and in accordance classifies it into a few portions. The report takes into consideration the prime market players in every area from over the globe.
Our research study analyses the size of the global market of Veterinary Oncology in primary regions such as North America, South America, Middle East & Africa, Asia Pacific and Europe. It also classifies the Veterinary Oncology Market by key manufacturers, region, type and application. Furthermore, this study examines in the status of the market, market share, future trends, growth rate, competitive landscape, opportunities, market driving factors and restraints, and challenges.
To stay updated with the latest technology and functions of the industry, Crystal Market Research regularly performs interviews with several industry experts and visits for its expert research analysts. The data sources include but not limited to reports of company’s, international organizations and governments, MMI market surveys, and related industry news.
This report forecasts revenue growth at global, regional & country levels and provides an analysis on the industry trends in each of the sub-segments from 2017 to 2027. This report has segmented the Veterinary Oncology Market on the basis of fabric, product, application, and region:
By Region
- North America (US, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Turkey, Rest of MEA)
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- Boehringer Ingelheim International GmbH
- Elanco
- Zoetis
- PetCure Oncology
- Accuray Incorporated
- Varian Medical Systems, Inc.
- Nippon Zenyaku Kogyo Co. Ltd. (ZENOAQ)
- Morphogenesis
- Karyopharm
- Regeneus Ltd.
- OHC
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2027
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2022 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Veterinary Oncology Market, By Therapy, Estimates and Forecast, 2017-2027 ($Million)
o Surgery
o Radiotherapy
o Chemotherapy
o Immunotherapy
o Others
· Veterinary Oncology Market, By Animal, Estimates and Forecast, 2017-2027 ($Million)
o Canine
o Feline
· Veterinary Oncology Market, By Cancer, Estimates and Forecast, 2017-2027 ($Million)
o Lymphoma
o Mast Cell Cancer
o Mammary and Squamous Cell Cancer
o Others
· Veterinary Oncology Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o Boehringer Ingelheim International GmbH
o Elanco
o Zoetis
o PetCure Oncology
o Accuray Incorporated
o Varian Medical Systems, Inc.
o Nippon Zenyaku Kogyo Co. Ltd. (ZENOAQ)
o Morphogenesis
o Karyopharm
o Regeneus Ltd.
o OHC
· Veterinary Oncology Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Veterinary Oncology Market, By Country
o U.S. Veterinary Oncology Market
o Canada Veterinary Oncology Market
o Mexico Veterinary Oncology Market
o Europe
§ Europe Veterinary Oncology Market, By Country
o UK Veterinary Oncology Market
o Germany Veterinary Oncology Market
o France Veterinary Oncology Market
o Russia Veterinary Oncology Market
o Italy Veterinary Oncology Market
o Rest of Europe Veterinary Oncology Market
o Asia-Pacific
§ Asia-Pacific Veterinary Oncology Market, By Country
o China Veterinary Oncology Market
o Japan Veterinary Oncology Market
o South Korea Veterinary Oncology Market
o India Veterinary Oncology Market
o Southeast Asia Veterinary Oncology Market
o Rest of Asia-Pacific Veterinary Oncology Market
o South America
§ South America Veterinary Oncology Market
o Brazil Veterinary Oncology Market
o Argentina Veterinary Oncology Market
o Columbia Veterinary Oncology Market
o Rest of South America Veterinary Oncology Market
o Middle East and Africa
§ Middle East and Africa Veterinary Oncology Market
o Saudi Arabia Veterinary Oncology Market
o UAE Veterinary Oncology Market
o Egypt Veterinary Oncology Market
o Nigeria Veterinary Oncology Market
o South Africa Veterinary Oncology Market
o Turkey Veterinary Oncology Market
o Rest of MEA Veterinary Oncology Market
Table of Contents
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.2.4. Challenges
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Veterinary Oncology Market, By Therapy
5.1. Introduction
5.2. Global Veterinary Oncology Revenue and Market Share by Therapy (2017-2021)
5.2.1. Global Veterinary Oncology Revenue and Revenue Share by Therapy (2017-2021)
5.3. Surgery
5.3.1. Global Surgery Revenue and Growth Rate (2017-2021)
5.4. Radiotherapy
5.4.1. Global Radiotherapy Revenue and Growth Rate (2017-2021)
5.5. Chemotherapy
5.5.1. Global Chemotherapy Revenue and Growth Rate (2017-2021)
5.6. Immunotherapy
5.6.1. Global Immunotherapy Revenue and Growth Rate (2017-2021)
5.7. Others
5.7.1. Global Others Revenue and Growth Rate (2017-2021)
6. Veterinary Oncology Market, By Animal
6.1. Introduction
6.2. Global Veterinary Oncology Revenue and Market Share by Animal (2017-2021)
6.2.1. Global Veterinary Oncology Revenue and Revenue Share by Animal (2017-2021)
6.3. Canine
6.3.1. Global Canine Revenue and Growth Rate (2017-2021)
6.4. Feline
6.4.1. Global Feline Revenue and Growth Rate (2017-2021)
7. Veterinary Oncology Market, By Cancer
7.1. Introduction
7.2. Global Veterinary Oncology Revenue and Market Share by Cancer (2017-2021)
7.2.1. Global Veterinary Oncology Revenue and Revenue Share by Cancer (2017-2021)
7.3. Lymphoma
7.3.1. Global Lymphoma Revenue and Growth Rate (2017-2021)
7.4. Mast Cell Cancer
7.4.1. Global Mast Cell Cancer Revenue and Growth Rate (2017-2021)
7.5. Mammary and Squamous Cell Cancer
7.5.1. Global Mammary and Squamous Cell Cancer Revenue and Growth Rate (2017-2021)
7.6. Others
7.6.1. Global Others Revenue and Growth Rate (2017-2021)
8. Veterinary Oncology Market, By Region
8.1. Introduction
8.2. Global Veterinary Oncology Revenue and Market Share by Regions
8.2.1. Global Veterinary Oncology Revenue by Regions (2017-2021)
8.3. North America Veterinary Oncology by Countries
8.3.1. North America Veterinary Oncology Revenue and Growth Rate (2017-2021)
8.3.2. North America Veterinary Oncology Revenue (Million USD) by Countries (2017-2021)
8.3.3. United States
8.3.3.1. United States Veterinary Oncology Revenue (Millions USD) and Growth Rate (2017-2021)
8.3.4. Canada
8.3.4.1. Canada Veterinary Oncology Revenue (Millions USD) and Growth Rate (2017-2021)
8.3.5. Mexico
8.3.5.1. Mexico Veterinary Oncology Revenue (Millions USD) and Growth Rate (2017-2021)
8.4. Europe Veterinary Oncology by Countries
8.4.1. Europe Veterinary Oncology Revenue and Growth Rate (2017-2021)
8.4.2. Europe Veterinary Oncology Revenue (Million USD) by Countries (2017-2021)
8.4.3. Germany
8.4.3.1. Germany Veterinary Oncology Revenue (Millions USD) and Growth Rate (2017-2021)
8.4.4. France
8.4.4.1. France Veterinary Oncology Revenue (Millions USD) and Growth Rate (2017-2021)
8.4.5. UK
8.4.5.1. UK Veterinary Oncology Revenue (Millions USD) and Growth Rate (2017-2021)
8.4.6. Russia
8.4.6.1. Russia Veterinary Oncology Revenue (Millions USD) and Growth Rate (2017-2021)
8.4.7. Italy
8.4.7.1. Italy Veterinary Oncology Revenue (Millions USD) and Growth Rate (2017-2021)
8.4.8. Rest of Europe
8.4.8.1. Rest of Europe Veterinary Oncology Revenue (Millions USD) and Growth Rate (2017-2021)
8.5. Asia-Pacific Veterinary Oncology by Countries
8.5.1. Asia-Pacific Veterinary Oncology Revenue and Growth Rate (2017-2021)
8.5.2. Asia-Pacific Veterinary Oncology Revenue (Million USD) by Countries (2017-2021)
8.5.3. China
8.5.3.1. China Veterinary Oncology Revenue (Millions USD) and Growth Rate (2017-2021)
8.5.4. Japan
8.5.4.1. Japan Veterinary Oncology Revenue (Millions USD) and Growth Rate (2017-2021)
8.5.5. Korea
8.5.5.1. Korea Veterinary Oncology Revenue (Millions USD) and Growth Rate (2017-2021)
8.5.6. India
8.5.6.1. India Veterinary Oncology Revenue (Millions USD) and Growth Rate (2017-2021)
8.5.7. Southeast Asia
8.5.7.1. Southeast Asia Veterinary Oncology Revenue (Millions USD) and Growth Rate (2017-2021)
8.5.8. Rest of Asia-Pacific
8.5.8.1. Rest of Asia-Pacific Veterinary Oncology Revenue (Millions USD) and Growth Rate (2017-2021)
8.6. South America Veterinary Oncology by Countries
8.6.1. South America Veterinary Oncology Revenue and Growth Rate (2017-2021)
8.6.2. South America Veterinary Oncology Revenue (Million USD) by Countries (2017-2021)
8.6.3. Brazil
8.6.3.1. Brazil Veterinary Oncology Revenue (Millions USD) and Growth Rate (2017-2021)
8.6.4. Argentina
8.6.4.1. Argentina Veterinary Oncology Revenue (Millions USD) and Growth Rate (2017-2021)
8.6.5. Columbia
8.6.5.1. Columbia Veterinary Oncology Revenue (Millions USD) and Growth Rate (2017-2021)
8.6.6. Rest of South America
8.6.6.1. Rest of South America Veterinary Oncology Revenue (Millions USD) and Growth Rate (2017-2021)
8.7. Middle East and Africa Veterinary Oncology by Countries
8.7.1. Middle East and Africa Veterinary Oncology Revenue and Growth Rate (2017-2021)
8.7.2. Middle East and Africa Veterinary Oncology Revenue (Million USD) by Countries (2017-2021)
8.7.3. Saudi Arabia
8.7.3.1. Saudi Arabia Veterinary Oncology Revenue (Millions USD) and Growth Rate (2017-2021)
8.7.4. United Arab Emirates
8.7.4.1. United Arab Emirates Veterinary Oncology Revenue (Millions USD) and Growth Rate (2017-2021)
8.7.5. Egypt
8.7.5.1. Egypt Veterinary Oncology Revenue (Millions USD) and Growth Rate (2017-2021)
8.7.6. Nigeria
8.7.6.1. Nigeria Veterinary Oncology Revenue (Millions USD) and Growth Rate (2017-2021)
8.7.7. South Africa
8.7.7.1. South Africa Veterinary Oncology Revenue (Millions USD) and Growth Rate (2017-2021)
8.7.8. Turkey
8.7.8.1. Turkey Veterinary Oncology Revenue (Millions USD) and Growth Rate (2017-2021)
8.7.9. Rest of Middle East and Africa
8.7.9.1. Rest of Middle East and Africa Veterinary Oncology Revenue (Millions USD) and Growth Rate (2017-2021)
9. Company Profiles
9.1. Boehringer Ingelheim International GmbH
9.1.1. Business Overview
9.1.2. Service Portfolio
9.1.3. Strategic Developments
9.1.4. Financial Overview
9.2. Elanco
9.2.1. Business Overview
9.2.2. Service Portfolio
9.2.3. Strategic Developments
9.2.4. Financial Overview
9.3. Zoetis
9.3.1. Business Overview
9.3.2. Service Portfolio
9.3.3. Strategic Developments
9.3.4. Financial Overview
9.4. PetCure Oncology
9.4.1. Business Overview
9.4.2. Service Portfolio
9.4.3. Strategic Developments
9.4.4. Financial Overview
9.5. Accuray Incorporated
9.5.1. Business Overview
9.5.2. Service Portfolio
9.5.3. Strategic Developments
9.5.4. Financial Overview
9.6. Varian Medical Systems, Inc.
9.6.1. Business Overview
9.6.2. Service Portfolio
9.6.3. Strategic Developments
9.6.4. Financial Overview
9.7. Nippon Zenyaku Kogyo Co. Ltd. (ZENOAQ)
9.7.1. Business Overview
9.7.2. Service Portfolio
9.7.3. Strategic Developments
9.7.4. Financial Overview
9.8. Morphogenesis
9.8.1. Business Overview
9.8.2. Service Portfolio
9.8.3. Strategic Developments
9.8.4. Financial Overview
9.9. Karyopharm
9.9.1. Business Overview
9.9.2. Service Portfolio
9.9.3. Strategic Developments
9.9.4. Financial Overview
9.10. Regeneus Ltd.
9.10.1. Business Overview
9.10.2. Service Portfolio
9.10.3. Strategic Developments
9.10.4. Financial Overview
9.11. OHC
9.11.1. Business Overview
9.11.2. Service Portfolio
9.11.3. Strategic Developments
9.11.4. Financial Overview
10. Veterinary Oncology Market Forecast (2022-2027)
10.1. Global Veterinary Oncology Revenue (Millions USD) and Growth Rate (2022-2027)
10.2. Veterinary Oncology Market Forecast by Regions (2022-2027)
10.2.1. North America Veterinary Oncology Market Forecast (2022-2027)
10.2.1.1. United States Veterinary Oncology Market Forecast (2022-2027)
10.2.1.2. Canada Veterinary Oncology Market Forecast (2022-2027)
10.2.1.3. Mexico Veterinary Oncology Market Forecast (2022-2027)
10.2.2. Europe Veterinary Oncology Market Forecast (2022-2027)
10.2.2.1. Germany Veterinary Oncology Market Forecast (2022-2027)
10.2.2.2. France Veterinary Oncology Market Forecast (2022-2027)
10.2.2.3. UK Veterinary Oncology Market Forecast (2022-2027)
10.2.2.4. Russia Veterinary Oncology Market Forecast (2022-2027)
10.2.2.5. Italy Veterinary Oncology Market Forecast (2022-2027)
10.2.2.6. Rest of Europe Veterinary Oncology Market Forecast (2022-2027)
10.2.3. Asia-Pacific Veterinary Oncology Market Forecast (2022-2027)
10.2.3.1. China Veterinary Oncology Market Forecast (2022-2027)
10.2.3.2. Japan Veterinary Oncology Market Forecast (2022-2027)
10.2.3.3. Korea Veterinary Oncology Market Forecast (2022-2027)
10.2.3.4. India Veterinary Oncology Market Forecast (2022-2027)
10.2.3.5. Southeast Asia Veterinary Oncology Market Forecast (2022-2027)
10.2.3.6. Rest of Asia-Pacific Veterinary Oncology Market Forecast (2022-2027)
10.2.4. South America Veterinary Oncology Market Forecast (2022-2027)
10.2.4.1. Brazil Veterinary Oncology Market Forecast (2022-2027)
10.2.4.2. Argentina Veterinary Oncology Market Forecast (2022-2027)
10.2.4.3. Columbia Veterinary Oncology Market Forecast (2022-2027)
10.2.4.4. Rest of South America Veterinary Oncology Market Forecast (2022-2027)
10.2.5. Middle East and Africa Veterinary Oncology Market Forecast (2022-2027)
10.2.5.1. Saudi Arabia Veterinary Oncology Market Forecast (2022-2027)
10.2.5.2. United Arab Emirates Veterinary Oncology Market Forecast (2022-2027)
10.2.5.3. Egypt Veterinary Oncology Market Forecast (2022-2027)
10.2.5.4. Nigeria Veterinary Oncology Market Forecast (2022-2027)
10.2.5.5. South Africa Veterinary Oncology Market Forecast (2022-2027)
10.2.5.6. Turkey Veterinary Oncology Market Forecast (2022-2027)
10.2.5.7. Rest of Middle East and Africa Veterinary Oncology Market Forecast (2022-2027)
10.3. Veterinary Oncology Market Forecast by Therapy (2022-2027)
10.3.1. Veterinary Oncology Forecast by Therapy (2022-2027)
10.3.2. Veterinary Oncology Market Share Forecast by Therapy (2022-2027)
10.4. Veterinary Oncology Market Forecast by Animal (2022-2027)
10.4.1. Veterinary Oncology Forecast by Animal (2022-2027)
10.4.2. Veterinary Oncology Market Share Forecast by Animal (2022-2027)
10.5. Veterinary Oncology Market Forecast by Cancer (2022-2027)
10.5.1. Veterinary Oncology Forecast by Cancer (2022-2027)
10.5.2. Veterinary Oncology Market Share Forecast by Cancer (2022-2027)
11. List of Tables and Figures
Figure United States Veterinary Oncology Revenue (Million USD) and Growth Rate (2017-2027)
Figure Canada Veterinary Oncology Revenue (Million USD) and Growth Rate (2017-2027)
Figure Mexico Veterinary Oncology Revenue (Million USD) and Growth Rate (2017-2027)
Figure Germany Veterinary Oncology Revenue (Million USD) and Growth Rate (2017-2027)
Figure France Veterinary Oncology Revenue (Million USD) and Growth Rate (2017-2027)
Figure UK Veterinary Oncology Revenue (Million USD) and Growth Rate (2017-2027)
Figure Russia Veterinary Oncology Revenue (Million USD) and Growth Rate (2017-2027)
Figure Italy Veterinary Oncology Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Europe Veterinary Oncology Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Veterinary Oncology Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Veterinary Oncology Revenue (Million USD) and Growth Rate (2017-2027)
Figure Korea Veterinary Oncology Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Veterinary Oncology Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Veterinary Oncology Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Asia-Pacific Veterinary Oncology Revenue (Million USD) and Growth Rate (2017-2027)
Figure Brazil Veterinary Oncology Revenue (Million USD) and Growth Rate (2017-2027)
Figure Argentina Veterinary Oncology Revenue (Million USD) and Growth Rate (2017-2027)
Figure Columbia Veterinary Oncology Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of South America Veterinary Oncology Revenue (Million USD) and Growth Rate (2017-2027)
Figure Saudi Arabia Veterinary Oncology Revenue (Million USD) and Growth Rate (2017-2027)
Figure United Arab Emirates Veterinary Oncology Revenue (Million USD) and Growth Rate (2017-2027)
Figure Egypt Veterinary Oncology Revenue (Million USD) and Growth Rate (2017-2027)
Figure Nigeria Veterinary Oncology Revenue (Million USD) and Growth Rate (2017-2027)
Figure South Africa Veterinary Oncology Revenue (Million USD) and Growth Rate (2017-2027)
Figure Turkey Veterinary Oncology Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Middle East and Africa Veterinary Oncology Revenue (Million USD) and Growth Rate (2017-2027)
Table Global Veterinary Oncology Revenue and Revenue Share by Therapy (2017-2021)
Figure Global Surgery Revenue and Growth Rate (2017-2021)
Figure Global Radiotherapy Revenue and Growth Rate (2017-2021)
Figure Global Chemotherapy Revenue and Growth Rate (2017-2021)
Figure Global Immunotherapy Revenue and Growth Rate (2017-2021)
Figure Global Others Revenue and Growth Rate (2017-2021)
Table Global Veterinary Oncology Revenue and Revenue Share by Animal (2017-2021)
Figure Global Canine Revenue and Growth Rate (2017-2021)
Figure Global Feline Revenue and Growth Rate (2017-2021)
Table Global Veterinary Oncology Revenue and Revenue Share by Cancer (2017-2021)
Figure Global Lymphoma Revenue and Growth Rate (2017-2021)
Figure Global Mast Cell Cancer Revenue and Growth Rate (2017-2021)
Figure Global Mammary and Squamous Cell Cancer Revenue and Growth Rate (2017-2021)
Figure Global Others Revenue and Growth Rate (2017-2021)
Table Global Veterinary Oncology Revenue by Regions (2017-2021)
Figure North America Veterinary Oncology Growth Rate (2017-2021)
Figure North America Veterinary Oncology Revenue and Growth Rate (2017-2021)
Figure North America Veterinary Oncology by Countries (2017-2021)
Figure North America Veterinary Oncology Revenue (Million USD) by Countries (2017-2021)
Figure United States Veterinary Oncology Growth Rate (2017-2021)
Figure United States Veterinary Oncology Revenue (Millions USD) and Growth Rate (2017-2021)
Figure Canada Veterinary Oncology Growth Rate (2017-2021)
Figure Canada Veterinary Oncology Revenue (Millions USD) and Growth Rate (2017-2021)
Figure Mexico Veterinary Oncology Growth Rate (2017-2021)
Figure Mexico Veterinary Oncology Revenue (Millions USD) and Growth Rate (2017-2021)
Figure Europe Veterinary Oncology Growth Rate (2017-2021)
Figure Europe Veterinary Oncology Revenue and Growth Rate (2017-2021)
Figure Europe Veterinary Oncology by Countries (2017-2021)
Figure Europe Veterinary Oncology Revenue (Million USD) by Countries (2017-2021)
Figure Germany Veterinary Oncology Growth Rate (2017-2021)
Figure Germany Veterinary Oncology Revenue (Millions USD) and Growth Rate (2017-2021)
Figure France Veterinary Oncology Growth Rate (2017-2021)
Figure France Veterinary Oncology Revenue (Millions USD) and Growth Rate (2017-2021)
Figure UK Veterinary Oncology Growth Rate (2017-2021)
Figure UK Veterinary Oncology Revenue (Millions USD) and Growth Rate (2017-2021)
Figure Russia Veterinary Oncology Growth Rate (2017-2021)
Figure Russia Veterinary Oncology Revenue (Millions USD) and Growth Rate (2017-2021)
Figure Italy Veterinary Oncology Growth Rate (2017-2021)
Figure Italy Veterinary Oncology Revenue (Millions USD) and Growth Rate (2017-2021)
Figure Rest of Europe Veterinary Oncology Growth Rate (2017-2021)
Figure Rest of Europe Veterinary Oncology Revenue (Millions USD) and Growth Rate (2017-2021)
Figure Asia-Pacific Veterinary Oncology Growth Rate (2017-2021)
Figure Asia-Pacific Veterinary Oncology Revenue and Growth Rate (2017-2021)
Figure Asia-Pacific Veterinary Oncology by Countries (2017-2021)
Figure Asia-Pacific Veterinary Oncology Revenue (Million USD) by Countries (2017-2021)
Figure China Veterinary Oncology Growth Rate (2017-2021)
Figure China Veterinary Oncology Revenue (Millions USD) and Growth Rate (2017-2021)
Figure Japan Veterinary Oncology Growth Rate (2017-2021)
Figure Japan Veterinary Oncology Revenue (Millions USD) and Growth Rate (2017-2021)
Figure Korea Veterinary Oncology Growth Rate (2017-2021)
Figure Korea Veterinary Oncology Revenue (Millions USD) and Growth Rate (2017-2021)
Figure India Veterinary Oncology Growth Rate (2017-2021)
Figure India Veterinary Oncology Revenue (Millions USD) and Growth Rate (2017-2021)
Figure Southeast Asia Veterinary Oncology Growth Rate (2017-2021)
Figure Southeast Asia Veterinary Oncology Revenue (Millions USD) and Growth Rate (2017-2021)
Figure Rest of Asia-Pacific Veterinary Oncology Growth Rate (2017-2021)
Figure Rest of Asia-Pacific Veterinary Oncology Revenue (Millions USD) and Growth Rate (2017-2021)
Figure South America Veterinary Oncology Growth Rate (2017-2021)
Figure South America Veterinary Oncology Revenue and Growth Rate (2017-2021)
Figure South America Veterinary Oncology by Countries (2017-2021)
Figure South America Veterinary Oncology Revenue (Million USD) by Countries (2017-2021)
Figure Brazil Veterinary Oncology Growth Rate (2017-2021)
Figure Brazil Veterinary Oncology Revenue (Millions USD) and Growth Rate (2017-2021)
Figure Argentina Veterinary Oncology Growth Rate (2017-2021)
Figure Argentina Veterinary Oncology Revenue (Millions USD) and Growth Rate (2017-2021)
Figure Columbia Veterinary Oncology Growth Rate (2017-2021)
Figure Columbia Veterinary Oncology Revenue (Millions USD) and Growth Rate (2017-2021)
Figure Rest of South America Veterinary Oncology Growth Rate (2017-2021)
Figure Rest of South America Veterinary Oncology Revenue (Millions USD) and Growth Rate (2017-2021)
Figure Middle East and Africa Veterinary Oncology Growth Rate (2017-2021)
Figure Middle East and Africa Veterinary Oncology Revenue and Growth Rate (2017-2021)
Figure Middle East and Africa Veterinary Oncology by Countries (2017-2021)
Figure Middle East and Africa Veterinary Oncology Revenue (Million USD) by Countries (2017-2021)
Figure Saudi Arabia Veterinary Oncology Growth Rate (2017-2021)
Figure Saudi Arabia Veterinary Oncology Revenue (Millions USD) and Growth Rate (2017-2021)
Figure United Arab Emirates Veterinary Oncology Growth Rate (2017-2021)
Figure United Arab Emirates Veterinary Oncology Revenue (Millions USD) and Growth Rate (2017-2021)
Figure Egypt Veterinary Oncology Growth Rate (2017-2021)
Figure Egypt Veterinary Oncology Revenue (Millions USD) and Growth Rate (2017-2021)
Figure Nigeria Veterinary Oncology Growth Rate (2017-2021)
Figure Nigeria Veterinary Oncology Revenue (Millions USD) and Growth Rate (2017-2021)
Figure South Africa Veterinary Oncology Growth Rate (2017-2021)
Figure South Africa Veterinary Oncology Revenue (Millions USD) and Growth Rate (2017-2021)
Figure Turkey Veterinary Oncology Growth Rate (2017-2021)
Figure Turkey Veterinary Oncology Revenue (Millions USD) and Growth Rate (2017-2021)
Figure Rest of Middle East and Africa Veterinary Oncology Growth Rate (2017-2021)
Figure Rest of Middle East and Africa Veterinary Oncology Revenue (Millions USD) and Growth Rate (2017-2021)
Table Boehringer Ingelheim International GmbH Veterinary Oncology Financial Overview
Table Elanco Veterinary Oncology Financial Overview
Table Zoetis Veterinary Oncology Financial Overview
Table PetCure Oncology Veterinary Oncology Financial Overview
Table Accuray Incorporated Veterinary Oncology Financial Overview
Table Varian Medical Systems, Inc. Veterinary Oncology Financial Overview
Table Nippon Zenyaku Kogyo Co. Ltd. (ZENOAQ) Veterinary Oncology Financial Overview
Table Morphogenesis Veterinary Oncology Financial Overview
Table Karyopharm Veterinary Oncology Financial Overview
Table Regeneus Ltd. Veterinary Oncology Financial Overview
Table OHC Veterinary Oncology Financial Overview
Figure Global Veterinary Oncology Revenue (Millions USD) and Growth Rate (2022-2027)
Table Veterinary Oncology Market Forecast by Regions (2022-2027)
Figure North America Veterinary Oncology Market Forecast (2022-2027)
Figure United States Veterinary Oncology Market Forecast (2022-2027)
Figure Canada Veterinary Oncology Market Forecast (2022-2027)
Figure Mexico Veterinary Oncology Market Forecast (2022-2027)
Figure Europe Veterinary Oncology Market Forecast (2022-2027)
Figure Germany Veterinary Oncology Market Forecast (2022-2027)
Figure France Veterinary Oncology Market Forecast (2022-2027)
Figure UK Veterinary Oncology Market Forecast (2022-2027)
Figure Russia Veterinary Oncology Market Forecast (2022-2027)
Figure Italy Veterinary Oncology Market Forecast (2022-2027)
Figure Rest of Europe Veterinary Oncology Market Forecast (2022-2027)
Figure Asia-Pacific Veterinary Oncology Market Forecast (2022-2027)
Figure China Veterinary Oncology Market Forecast (2022-2027)
Figure Japan Veterinary Oncology Market Forecast (2022-2027)
Figure Korea Veterinary Oncology Market Forecast (2022-2027)
Figure India Veterinary Oncology Market Forecast (2022-2027)
Figure Southeast Asia Veterinary Oncology Market Forecast (2022-2027)
Figure Rest of Asia-Pacific Veterinary Oncology Market Forecast (2022-2027)
Figure South America Veterinary Oncology Market Forecast (2022-2027)
Figure Brazil Veterinary Oncology Market Forecast (2022-2027)
Figure Argentina Veterinary Oncology Market Forecast (2022-2027)
Figure Columbia Veterinary Oncology Market Forecast (2022-2027)
Figure Rest of South America Veterinary Oncology Market Forecast (2022-2027)
Figure Middle East and Africa Veterinary Oncology Market Forecast (2022-2027)
Figure Saudi Arabia Veterinary Oncology Market Forecast (2022-2027)
Figure United Arab Emirates Veterinary Oncology Market Forecast (2022-2027)
Figure Egypt Veterinary Oncology Market Forecast (2022-2027)
Figure Nigeria Veterinary Oncology Market Forecast (2022-2027)
Figure South Africa Veterinary Oncology Market Forecast (2022-2027)
Figure Turkey Veterinary Oncology Market Forecast (2022-2027)
Figure Rest of Middle East and Africa Veterinary Oncology Market Forecast (2022-2027)
Figure Global Veterinary Oncology Forecast by Therapy (2022-2027)
Figure Global Veterinary Oncology Market Share Forecast by Therapy (2022-2027)
Figure Global Veterinary Oncology Forecast by Therapy (2022-2027)
Figure Global Veterinary Oncology Forecast by Animal (2022-2027)
Figure Global Veterinary Oncology Market Share Forecast by Animal (2022-2027)
Figure Global Veterinary Oncology Forecast by Animal (2022-2027)
Figure Global Veterinary Oncology Forecast by Cancer (2022-2027)
Figure Global Veterinary Oncology Market Share Forecast by Cancer (2022-2027)
Figure Global Veterinary Oncology Forecast by Cancer (2022-2027)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|